Are you over 18 and want to see adult content?
More Annotations
![A complete backup of https://x.yump3.ws/descargar-mp3/compre-una-cantina](https://www.archivebay.com/archive6/images/1e479bdb-2b1c-4db9-af55-d7f99a885f71.png)
A complete backup of https://x.yump3.ws/descargar-mp3/compre-una-cantina
Are you over 18 and want to see adult content?
![A complete backup of https://za.pinterest.com/pin/615022892838995927/](https://www.archivebay.com/archive6/images/b1945646-4eed-4082-9055-40ccc1700538.png)
A complete backup of https://za.pinterest.com/pin/615022892838995927/
Are you over 18 and want to see adult content?
![A complete backup of https://www.mutaz.net/free-programs/en/download/?688](https://www.archivebay.com/archive6/images/d99c54a3-905b-4409-bf46-36d77fe197c8.png)
A complete backup of https://www.mutaz.net/free-programs/en/download/?688
Are you over 18 and want to see adult content?
![A complete backup of https://www.bmi.ir/news/news/details/16958](https://www.archivebay.com/archive6/images/3235357e-9bb3-4aa3-9242-97dbb1df1db2.png)
A complete backup of https://www.bmi.ir/news/news/details/16958
Are you over 18 and want to see adult content?
![A complete backup of https://trustscam.com/bmboption.com](https://www.archivebay.com/archive6/images/4f5ed768-45b9-478f-9a8c-6661f4a6a845.png)
A complete backup of https://trustscam.com/bmboption.com
Are you over 18 and want to see adult content?
![A complete backup of https://negavetiveseovn.wordpress.com/](https://www.archivebay.com/archive6/images/ad5392a7-a43e-450a-83ac-771728db548a.png)
A complete backup of https://negavetiveseovn.wordpress.com/
Are you over 18 and want to see adult content?
![A complete backup of https://www.google.com/finance](https://www.archivebay.com/archive6/images/09c93fb4-22ac-4ca5-82d0-28ab6f82160e.png)
A complete backup of https://www.google.com/finance
Are you over 18 and want to see adult content?
![A complete backup of https://www.kaufmich.com/Paris_Paris](https://www.archivebay.com/archive6/images/f2ef4e9a-5c07-441e-9c34-cbeda2233f21.png)
A complete backup of https://www.kaufmich.com/Paris_Paris
Are you over 18 and want to see adult content?
![A complete backup of http://www.mtv.co.uk/music](https://www.archivebay.com/archive6/images/c9ecc645-dc84-4706-98ab-8fa5b53a14cd.png)
A complete backup of http://www.mtv.co.uk/music
Are you over 18 and want to see adult content?
![A complete backup of https://kawasantogel.blogspot.com/](https://www.archivebay.com/archive6/images/a290e671-1d61-453d-b8dd-bd7dbc26b4e2.png)
A complete backup of https://kawasantogel.blogspot.com/
Are you over 18 and want to see adult content?
![A complete backup of https://apple317.blogspot.com/](https://www.archivebay.com/archive6/images/ba74eb31-08fe-444d-a50d-ece5d84a4253.png)
A complete backup of https://apple317.blogspot.com/
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of https://mojnews.com](https://www.archivebay.com/archive6/images/caa9a22c-6f7f-429c-b2c7-8fc75c64e2ec.png)
A complete backup of https://mojnews.com
Are you over 18 and want to see adult content?
![A complete backup of https://renfrewshire24.co.uk](https://www.archivebay.com/archive6/images/e05efff6-fc1d-4521-9fa9-0fe41e1d6be8.png)
A complete backup of https://renfrewshire24.co.uk
Are you over 18 and want to see adult content?
![A complete backup of https://rivaracing.com](https://www.archivebay.com/archive6/images/b322f1d8-18da-4155-aca1-d9b2284622ec.png)
A complete backup of https://rivaracing.com
Are you over 18 and want to see adult content?
![A complete backup of https://xialingying.cc](https://www.archivebay.com/archive6/images/7705edcf-100f-4e15-917f-dd469ecbc3ab.png)
A complete backup of https://xialingying.cc
Are you over 18 and want to see adult content?
![A complete backup of https://wagconsulting.in](https://www.archivebay.com/archive6/images/76c21d1c-5bd1-4d3e-946d-d4e070872349.png)
A complete backup of https://wagconsulting.in
Are you over 18 and want to see adult content?
![A complete backup of https://schoolstickers.com](https://www.archivebay.com/archive6/images/2148db35-eee2-43b0-a13b-fc82c68f30e7.png)
A complete backup of https://schoolstickers.com
Are you over 18 and want to see adult content?
![A complete backup of https://sleeping.town](https://www.archivebay.com/archive6/images/eebd2647-0ed7-4821-bed4-f371e8961d25.png)
A complete backup of https://sleeping.town
Are you over 18 and want to see adult content?
![A complete backup of https://geneflux.net.my](https://www.archivebay.com/archive6/images/8f004062-dd3e-4db3-8081-398762244444.png)
A complete backup of https://geneflux.net.my
Are you over 18 and want to see adult content?
![A complete backup of https://dokari.gr](https://www.archivebay.com/archive6/images/f5d92241-4d9e-4807-aba0-913ff7d0104a.png)
A complete backup of https://dokari.gr
Are you over 18 and want to see adult content?
![A complete backup of https://sigmatraffic.com](https://www.archivebay.com/archive6/images/aa331e81-5d97-438c-95fd-2934e5c82056.png)
A complete backup of https://sigmatraffic.com
Are you over 18 and want to see adult content?
![A complete backup of https://zumschneider.com](https://www.archivebay.com/archive6/images/6092b9c6-7b43-469a-96d7-926a609d825e.png)
A complete backup of https://zumschneider.com
Are you over 18 and want to see adult content?
![A complete backup of https://fessl.ru](https://www.archivebay.com/archive6/images/d122479c-5dbf-4915-b3d6-d9c64f3d2a7e.png)
A complete backup of https://fessl.ru
Are you over 18 and want to see adult content?
Text
CAMBREX - CDMO
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle. Quality & regulatory. We deliver quality in every aspect of our work, across all of our facilities, systems and teams. Environment, health & safety. Our strong commitment to the environment and health and safety underpins all that we do atSMALL MOLECULE CDMO
Overview. From our highly compliant cGMP drug product facility in Mirabel, we offer drug product manufacturing and packaging. The facility located just outside Montreal, Canada has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant uses cutting-edge laboratory and manufacturingtechnologies.
SMALL MOLECULE CDMO
Our Charles City site is fully equipped with state of the art facilities, including the following: 4 cGMP commercial scale production plants. 1 cGMP pilot plant. 1 cGMP kilo laboratory. 350,000L commercial capacity. R&D development and analytical laboratories. High potency development and manufacturing center. Strong regulatory history.SMALL MOLECULE CDMO
This space is 3,000 square feet and is located 32 miles from the heart of the Cambridge-Boston area. For the convenience of our sponsors, the Agawam site also employ’s a courier service that is available to our clients within a 150 mile radius of the Agawam facility (located at 104 Gold Street, Agawam MA). Our experts will pick up and deliverSMALL MOLECULE CDMO
Overview. From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities (NCEs) and intermediates from grams to tons, through all phases of your drug’s lifecycle. Home to a team of more than 400 employees, the site is comprised of a combination of GMP and non-GMP work areas acrossseveral buildings.
SMALL MOLECULE CDMO
Overview. From our site in Longmont, CO, USA, we develop and manufacture small molecule drug substances and drug products with full analytical development and cGMP testing support. Home to a team of more than 90 employees, the site is comprised of four cGMP drug substance production suites with capacity up to 200 L, as well as twonon-GMP scale
SMALL MOLECULE CDMO
Overview. From our site in Durham, NC we offer the following services; analytical development & testing, process chemistry, API manufacturing, and stability storage & testing. Home to a team of 100+ people, the site is comprised of 100,900 square feet. The site includes state-of-the-art analytical instrumentation, non-GMP and cGMPkilo labs
SMALL MOLECULE CDMO
Overview. From our site in Paullo, Italy, we develop and manufacture generic and branded APIs and advanced intermediates to a commercial scale. Our product portfolio currently includes over 90 generic APIs, which are manufactured to cGMP standards. Home to a team of more than 300 employees, the site is comprised of seven pharmaceuticalSMALL MOLECULE CDMO
Overview. Our Whippany, NJ, USA facility provides cGMP compliant manufacturing and packaging services. The facility has an excellent FDA, MHRA and DEA compliance record. With state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulationtechnologies.
SMALL MOLECULE CDMO
Our facility is about to undergo rapid expansion and reflects the continued growth in our reputation and success in supporting our clients solid state and standalone analytical activities. With more than 50 employees, Cambrex Edinburgh offers a range of career opportunities, with roles including, Chemical Engineers, Synthetic andApplied
CAMBREX - CDMO
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle. Quality & regulatory. We deliver quality in every aspect of our work, across all of our facilities, systems and teams. Environment, health & safety. Our strong commitment to the environment and health and safety underpins all that we do atSMALL MOLECULE CDMO
Overview. From our highly compliant cGMP drug product facility in Mirabel, we offer drug product manufacturing and packaging. The facility located just outside Montreal, Canada has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant uses cutting-edge laboratory and manufacturingtechnologies.
SMALL MOLECULE CDMO
Our Charles City site is fully equipped with state of the art facilities, including the following: 4 cGMP commercial scale production plants. 1 cGMP pilot plant. 1 cGMP kilo laboratory. 350,000L commercial capacity. R&D development and analytical laboratories. High potency development and manufacturing center. Strong regulatory history.SMALL MOLECULE CDMO
This space is 3,000 square feet and is located 32 miles from the heart of the Cambridge-Boston area. For the convenience of our sponsors, the Agawam site also employ’s a courier service that is available to our clients within a 150 mile radius of the Agawam facility (located at 104 Gold Street, Agawam MA). Our experts will pick up and deliverSMALL MOLECULE CDMO
Overview. From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities (NCEs) and intermediates from grams to tons, through all phases of your drug’s lifecycle. Home to a team of more than 400 employees, the site is comprised of a combination of GMP and non-GMP work areas acrossseveral buildings.
SMALL MOLECULE CDMO
Overview. From our site in Longmont, CO, USA, we develop and manufacture small molecule drug substances and drug products with full analytical development and cGMP testing support. Home to a team of more than 90 employees, the site is comprised of four cGMP drug substance production suites with capacity up to 200 L, as well as twonon-GMP scale
SMALL MOLECULE CDMO
Overview. From our site in Durham, NC we offer the following services; analytical development & testing, process chemistry, API manufacturing, and stability storage & testing. Home to a team of 100+ people, the site is comprised of 100,900 square feet. The site includes state-of-the-art analytical instrumentation, non-GMP and cGMPkilo labs
SMALL MOLECULE CDMO
Overview. From our site in Paullo, Italy, we develop and manufacture generic and branded APIs and advanced intermediates to a commercial scale. Our product portfolio currently includes over 90 generic APIs, which are manufactured to cGMP standards. Home to a team of more than 300 employees, the site is comprised of seven pharmaceuticalSMALL MOLECULE CDMO
Overview. Our Whippany, NJ, USA facility provides cGMP compliant manufacturing and packaging services. The facility has an excellent FDA, MHRA and DEA compliance record. With state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulationtechnologies.
SMALL MOLECULE CDMO
Our facility is about to undergo rapid expansion and reflects the continued growth in our reputation and success in supporting our clients solid state and standalone analytical activities. With more than 50 employees, Cambrex Edinburgh offers a range of career opportunities, with roles including, Chemical Engineers, Synthetic andApplied
CDMO | DRUG SUBSTANCE, DRUG PRODUCT & ANALYTICAL SERVICES Your molecule Our mission . Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Learnmore
SMALL MOLECULE CDMO
History. Since its creation in 1981, Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics. With over 35 years’ experience and a growing team of over 2,000 experts servicing global clients from our sites in North America and Europe, we are tried and trusted in brandedand
SMALL MOLECULE CDMO
Overview. From our site in Paullo, Italy, we develop and manufacture generic and branded APIs and advanced intermediates to a commercial scale. Our product portfolio currently includes over 90 generic APIs, which are manufactured to cGMP standards. Home to a team of more than 300 employees, the site is comprised of seven pharmaceutical CDMO | NEWS | CAMBREX TO INVEST 50 MILLION IN US | CAMBREX Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabilities in the U.S. November 17, 2020. The expansion, which will be operational in early 2022, will increase API manufacturing capacity to meet current customer needs and support growing demand within the industry. East Rutherford, NJ – November17, 2020
SMALL MOLECULE CDMO
About the region. With a community of 50,000 residents, Mirabel is one of the largest municipal territories in Quebec. The site is located just 30 minutes north of Montreal and 20 minutes south of the Laurentians mountains where it is possible to get involved in a number of outdoor activities all throughout the year.SMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III. Home to a team of more than 90 employees, the site has a 25,000 sqEPINEPHRINE
Product code. 51-43-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs. Controlled substances. Speak to oneof. our experts.
CASE STUDY - ULTRA-HIGH POTENCY DEVELOPMENT - CAMBREX The Issue. While reviewing the toxicological data of the highly potent compound, the development team, in conjunction with a board certified toxicologist, discovered the compound to be “ultra-highly” potent (1-10 ng/m3 OEL – a low nanomolar range) that is orders of magnitude more potent than previously handled at any Cambrex facility. CDMO | NEWS | CAMBREX TO BE ACQUIRED BY THE PERMIRA FUNDS EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) — Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced today that it has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion CDMO | NEWS | AQUISITION OF AVISTA PHARMA SOLUTIONS | CAMBREX The acquisition of Avista was funded with a combination of cash on hand and borrowings under Cambrex’s new senior secured credit facility, following a refinancing that was also completed today. The new facility, which replaces Cambrex’s prior facility, includes a 5-year $200 million term loan and a $600 million revolving creditfacility.
CAMBREX - CDMO
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle. Quality & regulatory. We deliver quality in every aspect of our work, across all of our facilities, systems and teams. Environment, health & safety. Our strong commitment to the environment and health and safety underpins all that we do atSMALL MOLECULE CDMO
Overview. From our highly compliant cGMP drug product facility in Mirabel, we offer drug product manufacturing and packaging. The facility located just outside Montreal, Canada has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant uses cutting-edge laboratory and manufacturingtechnologies.
SMALL MOLECULE CDMO
This space is 3,000 square feet and is located 32 miles from the heart of the Cambridge-Boston area. For the convenience of our sponsors, the Agawam site also employ’s a courier service that is available to our clients within a 150 mile radius of the Agawam facility (located at 104 Gold Street, Agawam MA). Our experts will pick up and deliverSMALL MOLECULE CDMO
Overview. From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities (NCEs) and intermediates from grams to tons, through all phases of your drug’s lifecycle. Home to a team of more than 400 employees, the site is comprised of a combination of GMP and non-GMP work areas acrossseveral buildings.
SMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III. Home to a team of more than 90 employees, the site has a 25,000 sqSMALL MOLECULE CDMO
Our facility is about to undergo rapid expansion and reflects the continued growth in our reputation and success in supporting our clients solid state and standalone analytical activities. With more than 50 employees, Cambrex Edinburgh offers a range of career opportunities, with roles including, Chemical Engineers, Synthetic andApplied
SMALL MOLECULE CDMO
Overview. Our Whippany, NJ, USA facility provides cGMP compliant manufacturing and packaging services. The facility has an excellent FDA, MHRA and DEA compliance record. With state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulationtechnologies.
WEBINAR – UNDERSTANDING THE IMPORTANCE OF CRYSTALLIZATION Understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays Wednesday May 27, 2020 – 10am EST/ 4pm CET Cambrex will be hosting a live webinar on understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays and we would like to invite you to join us.TEMAZEPAM - CAMBREX
Product code. 846-50-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs.CHINA ARCHIVES
News sign up. Be the first to receive our latest news updates. EmailAddress . Contact
CAMBREX - CDMO
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle. Quality & regulatory. We deliver quality in every aspect of our work, across all of our facilities, systems and teams. Environment, health & safety. Our strong commitment to the environment and health and safety underpins all that we do atSMALL MOLECULE CDMO
Overview. From our highly compliant cGMP drug product facility in Mirabel, we offer drug product manufacturing and packaging. The facility located just outside Montreal, Canada has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant uses cutting-edge laboratory and manufacturingtechnologies.
SMALL MOLECULE CDMO
This space is 3,000 square feet and is located 32 miles from the heart of the Cambridge-Boston area. For the convenience of our sponsors, the Agawam site also employ’s a courier service that is available to our clients within a 150 mile radius of the Agawam facility (located at 104 Gold Street, Agawam MA). Our experts will pick up and deliverSMALL MOLECULE CDMO
Overview. From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities (NCEs) and intermediates from grams to tons, through all phases of your drug’s lifecycle. Home to a team of more than 400 employees, the site is comprised of a combination of GMP and non-GMP work areas acrossseveral buildings.
SMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III. Home to a team of more than 90 employees, the site has a 25,000 sqSMALL MOLECULE CDMO
Our facility is about to undergo rapid expansion and reflects the continued growth in our reputation and success in supporting our clients solid state and standalone analytical activities. With more than 50 employees, Cambrex Edinburgh offers a range of career opportunities, with roles including, Chemical Engineers, Synthetic andApplied
SMALL MOLECULE CDMO
Overview. Our Whippany, NJ, USA facility provides cGMP compliant manufacturing and packaging services. The facility has an excellent FDA, MHRA and DEA compliance record. With state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulationtechnologies.
WEBINAR – UNDERSTANDING THE IMPORTANCE OF CRYSTALLIZATION Understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays Wednesday May 27, 2020 – 10am EST/ 4pm CET Cambrex will be hosting a live webinar on understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays and we would like to invite you to join us.TEMAZEPAM - CAMBREX
Product code. 846-50-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs.CHINA ARCHIVES
News sign up. Be the first to receive our latest news updates. EmailAddress . Contact
CDMO | DRUG SUBSTANCE, DRUG PRODUCT & ANALYTICAL SERVICES Your molecule Our mission . Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Learnmore
SMALL MOLECULE CDMO
Create a better world at Cambrex. Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Known for our manufacturing excellence, experience and innovative science, we offer a range of career opportunities across our global network of locations.SMALL MOLECULE CDMO
History. Since its creation in 1981, Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics. With over 35 years’ experience and a growing team of over 2,000 experts servicing global clients from our sites in North America and Europe, we are tried and trusted in brandedand
SMALL MOLECULE CDMO
Our Charles City site is fully equipped with state of the art facilities, including the following: 4 cGMP commercial scale production plants. 1 cGMP pilot plant. 1 cGMP kilo laboratory. 350,000L commercial capacity. R&D development and analytical laboratories. High potency development and manufacturing center. Strong regulatory history.SMALL MOLECULE CDMO
We have forms and certificates for our Agawam, MA, Durham, NC and Longmont, CO USA sites. If you require any additional information,please contact us.
SMALL MOLECULE CDMO
Overview. From our site in Longmont, CO, USA, we develop and manufacture small molecule drug substances and drug products with full analytical development and cGMP testing support. Home to a team of more than 90 employees, the site is comprised of four cGMP drug substance production suites with capacity up to 200 L, as well as twonon-GMP scale
SMALL MOLECULE CDMO
Overview. From our site in Paullo, Italy, we develop and manufacture generic and branded APIs and advanced intermediates to a commercial scale. Our product portfolio currently includes over 90 generic APIs, which are manufactured to cGMP standards. Home to a team of more than 300 employees, the site is comprised of seven pharmaceuticalEPINEPHRINE
Product code. 51-43-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs. Controlled substances. Speak to oneof. our experts.
CASE STUDY - ULTRA-HIGH POTENCY DEVELOPMENT - CAMBREX The Issue. While reviewing the toxicological data of the highly potent compound, the development team, in conjunction with a board certified toxicologist, discovered the compound to be “ultra-highly” potent (1-10 ng/m3 OEL – a low nanomolar range) that is orders of magnitude more potent than previously handled at any Cambrex facility. CDMO | NEWS | CAMBREX TO BE ACQUIRED BY THE PERMIRA FUNDS EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) — Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced today that it has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billionCAMBREX - CDMO
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle. Quality & regulatory. We deliver quality in every aspect of our work, across all of our facilities, systems and teams. Environment, health & safety. Our strong commitment to the environment and health and safety underpins all that we do atSMALL MOLECULE CDMO
Overview. From our highly compliant cGMP drug product facility in Mirabel, we offer drug product manufacturing and packaging. The facility located just outside Montreal, Canada has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant uses cutting-edge laboratory and manufacturingtechnologies.
SMALL MOLECULE CDMO
Our facility is about to undergo rapid expansion and reflects the continued growth in our reputation and success in supporting our clients solid state and standalone analytical activities. With more than 50 employees, Cambrex Edinburgh offers a range of career opportunities, with roles including, Chemical Engineers, Synthetic andApplied
SMALL MOLECULE CDMO
This space is 3,000 square feet and is located 32 miles from the heart of the Cambridge-Boston area. For the convenience of our sponsors, the Agawam site also employ’s a courier service that is available to our clients within a 150 mile radius of the Agawam facility (located at 104 Gold Street, Agawam MA). Our experts will pick up and deliverSMALL MOLECULE CDMO
Overview. From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities (NCEs) and intermediates from grams to tons, through all phases of your drug’s lifecycle. Home to a team of more than 400 employees, the site is comprised of a combination of GMP and non-GMP work areas acrossseveral buildings.
CHINA ARCHIVES
News sign up. Be the first to receive our latest news updates. EmailAddress . Contact
SMALL MOLECULE CDMO
Overview. From our site in Durham, NC we offer the following services; analytical development & testing, process chemistry, API manufacturing, and stability storage & testing. Home to a team of 100+ people, the site is comprised of 100,900 square feet. The site includes state-of-the-art analytical instrumentation, non-GMP and cGMPkilo labs
SMALL MOLECULE CDMO
Overview. Our Whippany, NJ, USA facility provides cGMP compliant manufacturing and packaging services. The facility has an excellent FDA, MHRA and DEA compliance record. With state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulationtechnologies.
TEMAZEPAM - CAMBREX
Product code. 846-50-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs.SMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III. Home to a team of more than 90 employees, the site has a 25,000 sqCAMBREX - CDMO
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle. Quality & regulatory. We deliver quality in every aspect of our work, across all of our facilities, systems and teams. Environment, health & safety. Our strong commitment to the environment and health and safety underpins all that we do atSMALL MOLECULE CDMO
Overview. From our highly compliant cGMP drug product facility in Mirabel, we offer drug product manufacturing and packaging. The facility located just outside Montreal, Canada has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant uses cutting-edge laboratory and manufacturingtechnologies.
SMALL MOLECULE CDMO
This space is 3,000 square feet and is located 32 miles from the heart of the Cambridge-Boston area. For the convenience of our sponsors, the Agawam site also employ’s a courier service that is available to our clients within a 150 mile radius of the Agawam facility (located at 104 Gold Street, Agawam MA). Our experts will pick up and deliverSMALL MOLECULE CDMO
Overview. From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities (NCEs) and intermediates from grams to tons, through all phases of your drug’s lifecycle. Home to a team of more than 400 employees, the site is comprised of a combination of GMP and non-GMP work areas acrossseveral buildings.
SMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III. Home to a team of more than 90 employees, the site has a 25,000 sqSMALL MOLECULE CDMO
Our facility is about to undergo rapid expansion and reflects the continued growth in our reputation and success in supporting our clients solid state and standalone analytical activities. With more than 50 employees, Cambrex Edinburgh offers a range of career opportunities, with roles including, Chemical Engineers, Synthetic andApplied
SMALL MOLECULE CDMO
Overview. Our Whippany, NJ, USA facility provides cGMP compliant manufacturing and packaging services. The facility has an excellent FDA, MHRA and DEA compliance record. With state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulationtechnologies.
WEBINAR – UNDERSTANDING THE IMPORTANCE OF CRYSTALLIZATION Understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays Wednesday May 27, 2020 – 10am EST/ 4pm CET Cambrex will be hosting a live webinar on understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays and we would like to invite you to join us.TEMAZEPAM - CAMBREX
Product code. 846-50-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs.CHINA ARCHIVES
News sign up. Be the first to receive our latest news updates. EmailAddress . Contact
CDMO | DRUG SUBSTANCE, DRUG PRODUCT & ANALYTICAL SERVICES Your molecule Our mission . Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Learnmore
SMALL MOLECULE CDMO
Create a better world at Cambrex. Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Known for our manufacturing excellence, experience and innovative science, we offer a range of career opportunities across our global network of locations.SMALL MOLECULE CDMO
History. Since its creation in 1981, Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics. With over 35 years’ experience and a growing team of over 2,000 experts servicing global clients from our sites in North America and Europe, we are tried and trusted in brandedand
SMALL MOLECULE CDMO
Our Charles City site is fully equipped with state of the art facilities, including the following: 4 cGMP commercial scale production plants. 1 cGMP pilot plant. 1 cGMP kilo laboratory. 350,000L commercial capacity. R&D development and analytical laboratories. High potency development and manufacturing center. Strong regulatory history.SMALL MOLECULE CDMO
We have forms and certificates for our Agawam, MA, Durham, NC and Longmont, CO USA sites. If you require any additional information,please contact us.
SMALL MOLECULE CDMO
Overview. From our site in Longmont, CO, USA, we develop and manufacture small molecule drug substances and drug products with full analytical development and cGMP testing support. Home to a team of more than 90 employees, the site is comprised of four cGMP drug substance production suites with capacity up to 200 L, as well as twonon-GMP scale
SMALL MOLECULE CDMO
Overview. From our site in Paullo, Italy, we develop and manufacture generic and branded APIs and advanced intermediates to a commercial scale. Our product portfolio currently includes over 90 generic APIs, which are manufactured to cGMP standards. Home to a team of more than 300 employees, the site is comprised of seven pharmaceuticalEPINEPHRINE
Product code. 51-43-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs. Controlled substances. Speak to oneof. our experts.
CASE STUDY - ULTRA-HIGH POTENCY DEVELOPMENT - CAMBREX The Issue. While reviewing the toxicological data of the highly potent compound, the development team, in conjunction with a board certified toxicologist, discovered the compound to be “ultra-highly” potent (1-10 ng/m3 OEL – a low nanomolar range) that is orders of magnitude more potent than previously handled at any Cambrex facility. CDMO | NEWS | CAMBREX TO BE ACQUIRED BY THE PERMIRA FUNDS EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) — Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced today that it has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billionCAMBREX - CDMO
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle. Quality & regulatory. We deliver quality in every aspect of our work, across all of our facilities, systems and teams. Environment, health & safety. Our strong commitment to the environment and health and safety underpins all that we do atSMALL MOLECULE CDMO
Overview. From our highly compliant cGMP drug product facility in Mirabel, we offer drug product manufacturing and packaging. The facility located just outside Montreal, Canada has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant uses cutting-edge laboratory and manufacturingtechnologies.
SMALL MOLECULE CDMO
Our facility is about to undergo rapid expansion and reflects the continued growth in our reputation and success in supporting our clients solid state and standalone analytical activities. With more than 50 employees, Cambrex Edinburgh offers a range of career opportunities, with roles including, Chemical Engineers, Synthetic andApplied
SMALL MOLECULE CDMO
This space is 3,000 square feet and is located 32 miles from the heart of the Cambridge-Boston area. For the convenience of our sponsors, the Agawam site also employ’s a courier service that is available to our clients within a 150 mile radius of the Agawam facility (located at 104 Gold Street, Agawam MA). Our experts will pick up and deliverSMALL MOLECULE CDMO
Overview. From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities (NCEs) and intermediates from grams to tons, through all phases of your drug’s lifecycle. Home to a team of more than 400 employees, the site is comprised of a combination of GMP and non-GMP work areas acrossseveral buildings.
CHINA ARCHIVES
News sign up. Be the first to receive our latest news updates. EmailAddress . Contact
SMALL MOLECULE CDMO
Overview. From our site in Durham, NC we offer the following services; analytical development & testing, process chemistry, API manufacturing, and stability storage & testing. Home to a team of 100+ people, the site is comprised of 100,900 square feet. The site includes state-of-the-art analytical instrumentation, non-GMP and cGMPkilo labs
SMALL MOLECULE CDMO
Overview. Our Whippany, NJ, USA facility provides cGMP compliant manufacturing and packaging services. The facility has an excellent FDA, MHRA and DEA compliance record. With state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulationtechnologies.
TEMAZEPAM - CAMBREX
Product code. 846-50-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs.SMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III. Home to a team of more than 90 employees, the site has a 25,000 sqCAMBREX - CDMO
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle. Quality & regulatory. We deliver quality in every aspect of our work, across all of our facilities, systems and teams. Environment, health & safety. Our strong commitment to the environment and health and safety underpins all that we do atSMALL MOLECULE CDMO
Overview. From our highly compliant cGMP drug product facility in Mirabel, we offer drug product manufacturing and packaging. The facility located just outside Montreal, Canada has an excellent compliance record. Continually updated with state-of-the-art equipment, the plant uses cutting-edge laboratory and manufacturingtechnologies.
SMALL MOLECULE CDMO
Our facility is about to undergo rapid expansion and reflects the continued growth in our reputation and success in supporting our clients solid state and standalone analytical activities. With more than 50 employees, Cambrex Edinburgh offers a range of career opportunities, with roles including, Chemical Engineers, Synthetic andApplied
SMALL MOLECULE CDMO
This space is 3,000 square feet and is located 32 miles from the heart of the Cambridge-Boston area. For the convenience of our sponsors, the Agawam site also employ’s a courier service that is available to our clients within a 150 mile radius of the Agawam facility (located at 104 Gold Street, Agawam MA). Our experts will pick up and deliverSMALL MOLECULE CDMO
Overview. From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities (NCEs) and intermediates from grams to tons, through all phases of your drug’s lifecycle. Home to a team of more than 400 employees, the site is comprised of a combination of GMP and non-GMP work areas acrossseveral buildings.
CHINA ARCHIVES
News sign up. Be the first to receive our latest news updates. EmailAddress . Contact
SMALL MOLECULE CDMO
Overview. From our site in Durham, NC we offer the following services; analytical development & testing, process chemistry, API manufacturing, and stability storage & testing. Home to a team of 100+ people, the site is comprised of 100,900 square feet. The site includes state-of-the-art analytical instrumentation, non-GMP and cGMPkilo labs
SMALL MOLECULE CDMO
Overview. Our Whippany, NJ, USA facility provides cGMP compliant manufacturing and packaging services. The facility has an excellent FDA, MHRA and DEA compliance record. With state-of-the-art equipment, the plant utilizes a variety of laboratory and manufacturing technologies including coating, compression and granulationtechnologies.
TEMAZEPAM - CAMBREX
Product code. 846-50-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs.SMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III. Home to a team of more than 90 employees, the site has a 25,000 sq CDMO | DRUG SUBSTANCE, DRUG PRODUCT & ANALYTICAL SERVICES Your molecule Our mission . Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Learnmore
SMALL MOLECULE CDMO
Create a better world at Cambrex. Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Known for our manufacturing excellence, experience and innovative science, we offer a range of career opportunities across our global network of locations.SMALL MOLECULE CDMO
History. Since its creation in 1981, Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics. With over 35 years’ experience and a growing team of over 2,000 experts servicing global clients from our sites in North America and Europe, we are tried and trusted in brandedand
SMALL MOLECULE CDMO
Our Charles City site is fully equipped with state of the art facilities, including the following: 4 cGMP commercial scale production plants. 1 cGMP pilot plant. 1 cGMP kilo laboratory. 350,000L commercial capacity. R&D development and analytical laboratories. High potency development and manufacturing center. Strong regulatory history.SMALL MOLECULE CDMO
We have forms and certificates for our Agawam, MA, Durham, NC and Longmont, CO USA sites. If you require any additional information,please contact us.
SMALL MOLECULE CDMO
Overview. From our site in Longmont, CO, USA, we develop and manufacture small molecule drug substances and drug products with full analytical development and cGMP testing support. Home to a team of more than 90 employees, the site is comprised of four cGMP drug substance production suites with capacity up to 200 L, as well as twonon-GMP scale
SMALL MOLECULE CDMO
Overview. From our site in Paullo, Italy, we develop and manufacture generic and branded APIs and advanced intermediates to a commercial scale. Our product portfolio currently includes over 90 generic APIs, which are manufactured to cGMP standards. Home to a team of more than 300 employees, the site is comprised of seven pharmaceuticalEPINEPHRINE
Product code. 51-43-4. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. Generic APIs. High potency APIs. Controlled substances. Speak to oneof. our experts.
CASE STUDY - ULTRA-HIGH POTENCY DEVELOPMENT - CAMBREX The Issue. While reviewing the toxicological data of the highly potent compound, the development team, in conjunction with a board certified toxicologist, discovered the compound to be “ultra-highly” potent (1-10 ng/m3 OEL – a low nanomolar range) that is orders of magnitude more potent than previously handled at any Cambrex facility. CDMO | NEWS | CAMBREX TO BE ACQUIRED BY THE PERMIRA FUNDS EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) — Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced today that it has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billionCAMBREX - CDMO
Your molecule Our mission . Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Learnmore
SMALL MOLECULE CDMO
We can handle small batch or high-volume manufacturing, for a wide range of solid dose, liquids – including suspensions and solutions, and non-sterile semi-solid forms – including lotions, creams and ointments and suppositories.SMALL MOLECULE CDMO
From our site in Agawam, MA, we offer a full suite of microbiological, analytical and environmental monitoring services to support pharmaceutical and medical device product development:SMALL MOLECULE CDMO
From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities and intermediates, through all phases of your drug’s lifecycle.SMALL MOLECULE CDMO
We provide world class solid form screening programmes and have an industry leading crystallization process development team with extensive experience in the scale-up ofSMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III.SMALL MOLECULE CDMO
We offer the following services; analytical development & testing, process chemistry, API manufacturing, and stability storage & testing. WEBINAR – UNDERSTANDING THE IMPORTANCE OF CRYSTALLIZATION Understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays Wednesday May 27, 2020 – 10am EST/ 4pm CET Cambrex will be hosting a live webinar on understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays and we would like to invite you to join us.TEMAZEPAM - CAMBREX
Find a Generic API. Cambrex is a leading global supplier of more than100 generic APIs.
CHINA ARCHIVES
News sign up. Be the first to receive our latest news updates. EmailAddress . Contact
CAMBREX - CDMO
Your molecule Our mission . Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Learnmore
SMALL MOLECULE CDMO
We can handle small batch or high-volume manufacturing, for a wide range of solid dose, liquids – including suspensions and solutions, and non-sterile semi-solid forms – including lotions, creams and ointments and suppositories.SMALL MOLECULE CDMO
From our site in Agawam, MA, we offer a full suite of microbiological, analytical and environmental monitoring services to support pharmaceutical and medical device product development:SMALL MOLECULE CDMO
From our site in Karlskoga, Sweden, we develop and manufacture small molecule APIs, new chemical entities and intermediates, through all phases of your drug’s lifecycle.SMALL MOLECULE CDMO
We provide world class solid form screening programmes and have an industry leading crystallization process development team with extensive experience in the scale-up ofSMALL MOLECULE CDMO
Focus and specialize in early phase clinical supply and process development. From our site in High Point, NC, USA, we develop, manufacture and scale-up small molecule Active Pharmaceutical Ingredients (APIs) and intermediates to support clinical trials from Phase I to Phase III.SMALL MOLECULE CDMO
We offer the following services; analytical development & testing, process chemistry, API manufacturing, and stability storage & testing. WEBINAR – UNDERSTANDING THE IMPORTANCE OF CRYSTALLIZATION Understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays Wednesday May 27, 2020 – 10am EST/ 4pm CET Cambrex will be hosting a live webinar on understanding the importance of crystallization processes to avoid unnecessary cost, risk and development delays and we would like to invite you to join us.TEMAZEPAM - CAMBREX
Find a Generic API. Cambrex is a leading global supplier of more than100 generic APIs.
CHINA ARCHIVES
News sign up. Be the first to receive our latest news updates. EmailAddress . Contact
CDMO | DRUG SUBSTANCE, DRUG PRODUCT & ANALYTICAL SERVICES Your molecule Our mission . Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Learnmore
SMALL MOLECULE CDMO
Create a better world at Cambrex. Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. CDMO | ANALYTICAL SERVICES | MICROBIOLOGY | CAMBREX Analytical solutions Quality assured . Our microbiology capabilities cover a range of processes, including Biological Indicator Testing, Heterotrophic Plate Count Testing, Disinfectant Qualification, Filter Integrity Testing, Microbial Identification, Antimicrobial Effectiveness Testing, Sterilization validations, Bioburden testing, Sterility testing, Endotoxin Testing, and Mycoplasma TestingSMALL MOLECULE CDMO
From our site in Charles City, IA, USA, we develop and manufacture small molecule APIs, fine chemicals and intermediates for a wide rangeof applications.
SMALL MOLECULE CDMO
We have forms and certificates for our Agawam, MA, Durham, NC and Longmont, CO USA sites. If you require any additional information,please contact us.
SMALL MOLECULE CDMO
Our site is equipped to handle potent compounds up to SafeBridge 3B for drug substances and 3A for drug products. The facility also has a research license for the handling of controlled substances.SMALL MOLECULE CDMO
From our site in Paullo, Italy, we develop and manufacture generic and branded APIs and advanced intermediates to a commercial scale. Our product portfolio currently includes over 90 generic APIs, which are manufactured to cGMP standards.EPINEPHRINE
Read about Epinephrine, one of our API products. The trademarks are the property of or licensed to Cambrex Corporation or its subsidiaries unless otherwise noted. CASE STUDY - ULTRA-HIGH POTENCY DEVELOPMENT - CAMBREX The Issue. While reviewing the toxicological data of the highly potent compound, the development team, in conjunction with a board certified toxicologist, discovered the compound to be “ultra-highly” potent (1-10 ng/m3 OEL – a low nanomolar range) that is orders of magnitude more potent than previously handled at any Cambrex facility. CDMO | NEWS | CAMBREX TO BE ACQUIRED BY THE PERMIRA FUNDS EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) — Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced today that it has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion Skip to content Open MenuSearch for:
* News & events
* Insight & resources* Facilities
* Careers
* Contact
* Drug substance
Back to main menu
*
Drug substance
* Custom development * Process development & validation * Analytical development & validation * Custom manufacturing * Technology transfer * Manufacturing capabilities * Quality & regulatory * Environment, health & safety* Generic APIs
* Product catalogue
* Controlled substances* High potency APIs
* Specialist technologies* Biocatalysis
* Continuous flow
* Controlled substances * Crystallization process development* High potency APIs
* Solid state science * Material characterization* Drug product
Back to main menu
*
Drug product
* Custom development * Formulation development * Analytical development & validation* Clinical supply
* Custom manufacturing * Technology transfer * Manufacturing capabilities * Quality & regulatory * Environment, health & safety* Packaging
* Conventional dosage forms* Solid dose
* Semi-solid dose
* Liquids
* Specialized dosage forms * Fixed-dose combinations* Pediatric
* Bi-layer tablets
* Stick packs
* Topicals
* Controlled substances * Sterile & non-sterile * Solid state science * Material characterization * Analytical servicesBack to main menu
*
Analytical services
* Compendial testing* Microbiology
* Cleanroom services * Release & QC testing * Extractables/leachables studies* Stability storage
* Method development & validation * Material characterization * Elemental impurities * Impurity isolation, identification & characterization * Reference standard qualification * Bioanalytical & biopharmaceutical analysisOpen Search
ERENA SAWYER-WAGNER
Manager
Quality Control
YOUR MOLECULE
OUR MISSION
Cambrex is THE small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the marketLearn more
Explore Cambrex
ABOUT US
Cambrex provides drug substance, drug product and analytical services across the entire drug lifecycle QUALITY & REGULATORY We deliver quality in every aspect of our work, across all of our facilities, systems and teams ENVIRONMENT, HEALTH & SAFETY Our strong commitment to the environment and health and safety underpins all that we do at CambrexCAMBREX CAREERS
At Cambrex, it’s our people that set us apart. We’re committed to attracting, nurturing and retaining a passionate and talented team of experts that enjoy what they do CAMBREX INTRODUCES NEW KILOGRAM-SCALE GMP MANUFACTURING CAPABILITIES AT TALLINN, ESTONIA FACILITY East Rutherford, NJ – May 26, 2021 – Cambrex today announced the completion of an investment project at its facility in Tallinn, Estonia to upgrade its kilogram-scale laboratory to undertake the manufacture of pharmaceutical intermediates under current good manufacturing practice (CGMP) conditions. The project includes the installation of a new 160-liter reactor train in the laboratory which will expand the site’s capabilities to manufacture material for clinical trials and allow early phase projects to be developed further at the site prior to tech transferand scale up.
Learn more
THE CAMBREX RIPPLE EFFECT The Cambrex ripple represents the dynamic energy and passion of our people. It’s symbolic of the positive impacts that every employee has on our business – every day – from personal connections through to teams, departments and sites. Our people add value to your end goals, help grow your business and we’re consistently told you enjoy working with us. Watch our video to learn how we can accelerate your small molecule therapeutics into the market.FIND A GENERIC API
Cambrex is a leading global supplier of more than 100 generic APIs.Find a generic API
* Find a therapeutic useADHDAdrenergic AgonistAlzheimer DiseaseAnalgesicAnti-allergicAnti-anginaAnti-anxietyAnti-arrhythmicAnti-asthmaticAnti-bacterialAnti-convulsantAnti-depressantAnti-emeticAnti-epilepticAnti-infectiveAnti-osteoporaticAnti-protozoalAnti-ulcerAntimigraine triptanAntiparathyroid productsAnxiolyticBeta-adrenergicBeta-adrenoreceptor AntagonistsBeta-blockerBronchodilatorCardiovascularCNSCoronary VasodilatorDermatological agentDiureticExpectorantHIV anti-viralsHypnoticHypoglycemicInflammatory Bowel DiseaseKeratolyticLaxativeLocal AnestheticNeurolepticProgestogen Anti-neoplasticSedativeSmoking Cessation AidSympathomimetic AgentSystemic AntifibrosisTranquilizerUrinary Incontinence Or search our A-Z generic product listOUR LOCATIONS
With over 35 years’ experience and a growing team of over 2,000 experts servicing our global clients from our sites in North America and Europe, we are tried and trusted in branded and generic markets for API and dosage form development and manufacturing. Cambrex can support your project in regulated, emerging and developing markets. We are in your neighborhood, wherever you are. HOW CAN CAMBREX HELP YOU ADVANCE?See our facilities
LATEST NEWS
Read more news
May 26, 2021
Cambrex Introduces New Kilogram-Scale GMP Manufacturing Capabilities at Tallinn, Estonia FacilityMay 5, 2021
Cambrex Expands Analytical Services Capabilities at Longmont,Colorado Facility
February 19, 2021
Cambrex Recognized in 2021 CMO Leadership AwardsNovember 17, 2020
Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabilities in the U.S.October 12, 2020
Cambrex Completes Major Expansion of Solid Form Screening Facility inEdinburgh
MEET CAMBREX AT...
Schedule a meeting
June 10, 2021
Webinar – Balancing Cost Efficiencies in the Drug DevelopmentProcess
June 23, 2021
Virtual HPAPI Summit CAMBREX ADDS EARLY STAGE API AND FINISHED DOSAGE FORM DEVELOPMENT & TESTING SERVICES TO ITS GLOBAL CONTRACT DEVELOPMENT & MANUFACTURING NETWORK THROUGH AVISTA PHARMA SOLUTIONS ACQUISITIONLearn more
Continue to Cambrex websiteNEWS SIGN UP
Be the first to receive our latest news updatesEmail Address
Contact
__ __
* About
* Recruitment policy* Privacy
* Sitemap
* Forms & Certificates* Manage Cookies
2007-2021 Cambrex Corporation. All rights reserved.Notifications
THIS SITE USES COOKIES TO STORE INFORMATION ON YOUR COMPUTER. Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used.AcceptDecline
-------------------------NECESSARY COOKIES
Necessary cookies enable core functionality such as page navigation and access to secure areas. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences. -------------------------ANALYTICAL COOKIES
Analytical cookies help us to improve our website by collecting and reporting information on its usage. Analytical CookiesOnOff -------------------------MARKETING COOKIES
We use marketing cookies to help us improve the relevancy of advertising campaigns you receive. Marketing CookiesOnOff -------------------------Save and close
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0